+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Study of associated clinical variables and phenomenology of hallucinations in Parkinson's



Study of associated clinical variables and phenomenology of hallucinations in Parkinson's



Neurologia 21(1): 12-18



Although hallucinations are considered to be a dopaminergic related phenomenon, the correlation between hallucinations with other features in Parkinson's disease (PD) still remains controversial. To define the phenomenology and factors that contribute to hallucinations in patients with idiopathic PD, and to determine their correlation with the Parkinsonian motor state (on versus off ). A consecutive series of patients with PD were examined using the motor subscale of the Unified Parkinson's Disease Rating Scale (UPDRSm), Hoehn and Yahr stage (HY), Mini-Mental State Examination (MMSE) and a questionnaire on hallucinations, motor state and sleep disorders. Patient's characteristics, treatment, motor status, and sleep disorders were correlated with the presence of hallucinations using parametric and non-parametric tests. Thirty eight patients (18 men, 20 women) with a mean age of 73.3 +/- 7 years, PD duration of 9 +/- 7 years, median HY stage of 2 (2-5), and a MMSE of 25 +/- 4 were included. Compared to non hallucinators (15 patients), hallucinators (23 patients) had a higher HY (p = 0.01), UPDRSm (p = 0.004), PD duration (p = 0.01), PD treatment duration (p = 0.03), presence of sleep disorders (p = 0.05) and were taking higher total daily doses of levodopa (p = 0.05). A multivariate analysis found that higher UPDRSm scores and total levodopa daily dose were the main clinical variables associated with hallucinations. Age, gender, MMSE scores, prior levodopa dose or dopaminergic agonists, and motor state did not influence the presence of hallucinations. In this study, hallucinations were not correlated with the Parkinsonian motor state. Although motor severity impairment and total levodopa daily dose were the main clinical variables associated with hallucinations, other clinical factors such as sleep disorders and treatment duration should be considered.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050426508

Download citation: RISBibTeXText

PMID: 16525921


Related references

Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 83(10): 1019-1021, 2012

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745, 2000

New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Review of Neurotherapeutics 7(12): 1731-1750, 2007

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745. American Journal of Ophthalmology 130(2): 261-262, 2000

Phenomenology, clinical diagnostics and treatment of hallucinations. Therapeutische Umschau. Revue Therapeutique 75(1): 19-29, 2018

"String Hallucinations": Multimodal Tactile and Visual Hallucinations in Parkinson's Disease. Movement Disorders Clinical Practice 3(2): 180-183, 2019

Hallucinations in Parkinson's disease: the clinical syndrome. Advances in Neurology 80: 419-423, 1999

Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology. Advances in Neurology 45: 357-360, 1987

Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue. Parkinsonism and Related Disorders 18(Suppl. 1): S222-S225, 2012

Informant- and Self-Appraisals on the Psychosis and Hallucinations Questionnaire (PsycH-Q) Enhances Detection of Visual Hallucinations in Parkinson's Disease. Movement Disorders Clinical Practice 5(6): 607-613, 2019

Hallucinations in Parkinson's disease Characteristics and associated clinical features. International Journal of Geriatric Psychiatry 10(6): 487-495, 1995

Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. Journal of Parkinson's Disease 3(1): 1-11, 2013

Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates. Rinsho Shinkeigaku 45(1): 1-5, 2005

Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease. Journal of Parkinson's Disease 2(3): 199-205, 2012

Hallucinations in Parkinson's disease: their clinical picture, pathophysiology and treatment. No to Shinkei 58(9): 747-755, 2006